Semler Scientific Crescita futura

Criteri Future verificati 0/6

Si prevede che i ricavi e gli utili di Semler Scientific diminuiranno rispettivamente del 33.5% e 126.6% all'anno, mentre si prevede che l'EPS diminuirà del 153.5% all'anno.

Informazioni chiave

-126.6%

Tasso di crescita degli utili

-153.54%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	12.7%
Tasso di crescita dei ricavi	-33.5%
Rendimento futuro del capitale proprio	n/a
Copertura analitica	Low
Ultimo aggiornamento	23 Sep 2025

Aggiornamenti recenti sulla crescita futura

Recent updates

Is Semler Scientific (NASDAQ:SMLR) Using Too Much Debt?

Aug 21

Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks

Aug 10 Diversification into cardiac disease markets and value-based care tools positions the company for higher recurring revenues and improved long-term margins.

Semler Scientific, Inc.'s (NASDAQ:SMLR) 26% Share Price Surge Not Quite Adding Up

Jul 09

Semler Scientific: Not The Ideal Bitcoin Treasury Company

May 29

Semler Scientific, Inc.'s (NASDAQ:SMLR) 32% Price Boost Is Out Of Tune With Revenues

May 17

Here's Why We Think Semler Scientific (NASDAQ:SMLR) Might Deserve Your Attention Today

Mar 25

Semler Scientific's (NASDAQ:SMLR) Profits May Not Reveal Underlying Issues

Mar 07

Semler Scientific, Inc. (NASDAQ:SMLR) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Mar 04

Semler Scientific, Inc. (NASDAQ:SMLR) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Jan 15

Semler Scientific: Booking Some Profits After Bitcoin Strategy

Dec 10

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Nov 02

Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders

Aug 14

The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet

Jul 18

We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease

May 08

Previsioni di crescita degli utili e dei ricavi

NasdaqCM:SMLR - Stime future degli analisti e dati finanziari passati (USD Millions )
Data	Ricavi	Utili	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2027	16	-31	N/A	N/A	1
12/31/2026	27	-12	-3	-10	3
12/31/2025	32	-3	-1	-3	3
6/30/2025	43	37	12	12	N/A
3/31/2025	49	-30	17	17	N/A
12/31/2024	56	41	24	24	N/A
9/30/2024	59	16	-47	21	N/A
6/30/2024	62	16	20	20	N/A
3/31/2024	66	22	26	26	N/A
12/31/2023	68	21	21	21	N/A
9/30/2023	67	20	17	19	N/A
6/30/2023	65	18	20	22	N/A
3/31/2023	61	16	14	17	N/A
12/31/2022	57	14	15	17	N/A
9/30/2022	54	13	16	17	N/A
6/30/2022	54	13	16	17	N/A
3/31/2022	54	16	12	13	N/A
12/31/2021	53	17	15	16	N/A
9/30/2021	54	21	19	20	N/A
6/30/2021	50	22	15	16	N/A
3/31/2021	42	16	15	16	N/A
12/31/2020	39	14	14	15	N/A
9/30/2020	36	11	12	13	N/A
6/30/2020	34	14	13	14	N/A
3/31/2020	35	16	13	15	N/A
12/31/2019	33	15	11	13	N/A
9/30/2019	30	14	10	11	N/A
6/30/2019	26	7	6	8	N/A
3/31/2019	24	6	N/A	7	N/A
12/31/2018	21	5	N/A	5	N/A
9/30/2018	20	4	N/A	3	N/A
6/30/2018	18	2	N/A	2	N/A
3/31/2018	15	0	N/A	1	N/A
12/31/2017	12	-2	N/A	1	N/A
9/30/2017	11	-2	N/A	0	N/A
6/30/2017	9	-2	N/A	0	N/A
3/31/2017	8	-2	N/A	-1	N/A
12/31/2016	7	-3	N/A	-2	N/A
9/30/2016	8	-7	N/A	-4	N/A
6/30/2016	7	-8	N/A	-3	N/A
3/31/2016	7	-8	N/A	-4	N/A
12/31/2015	7	-9	N/A	-4	N/A
9/30/2015	5	-5	N/A	-4	N/A
6/30/2015	4	-5	N/A	-4	N/A
3/31/2015	4	-5	N/A	-4	N/A
12/31/2014	4	-5	N/A	-4	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Si prevede che gli utili di SMLR diminuiranno nei prossimi 3 anni ( -126.6% all'anno).

Guadagni vs Mercato: Si prevede che gli utili di SMLR diminuiranno nei prossimi 3 anni ( -126.6% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di SMLR diminuiranno nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che i ricavi di SMLR diminuiranno nei prossimi 3 anni ( -33.5% all'anno).

Ricavi ad alta crescita: Si prevede che i ricavi di SMLR diminuiranno nei prossimi 3 anni ( -33.5% all'anno).

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di SMLR è previsto essere elevato tra 3 anni

Scoprire le aziende in crescita

Analisi aziendale e situazione dei dati finanziari

Dati	Ultimo aggiornamento (ora UTC)
Analisi dell'azienda	2025/10/06 00:54
Prezzo dell'azione a fine giornata	2025/10/06 00:00
Utili	2025/06/30
Utili annuali	2024/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

Pacchetto	Dati	Tempistica	Esempio Fonte USA ^*
Dati finanziari della società	10 anni	Conto economico Rendiconto finanziario Bilancio	Modulo SEC 10-K Modulo SEC 10-Q
Stime di consenso degli analisti	+3 anni	Previsioni finanziarie Obiettivi di prezzo degli analisti	Rapporti di ricerca degli analisti Blue Matrix
Prezzi di mercato	30 anni	Prezzi delle azioni Dividendi, scissioni e azioni	Dati di mercato ICE Modulo SEC S-1
Proprietà	10 anni	Top azionisti Insider trading	Modulo 4 SEC Modulo 13D SEC
Gestione	10 anni	Team di leadership Consiglio di amministrazione	Modulo SEC 10-K Modulo SEC DEF 14A
Sviluppi principali	10 anni	Annunci aziendali	Modulo 8-K SEC

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Semler Scientific, Inc. è coperta da 5 analisti. 3 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

Analista	Istituzione
Mark Palmer	Benchmark Company
Marc Wiesenberger	B. Riley Securities, Inc.
Brett Knoblauch	Cantor Fitzgerald & Co.

Semler Scientific Crescita futura

Criteri Future verificati 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target decreased by 12% to US$75.33

Consensus EPS estimates increase from loss to US$0.24 profit

Consensus EPS estimates increase by 26%

Price target decreased by 38% to US$40.00

Recent updates

Semler Scientific, Inc. & Bard Peripheral Vascular, Inc. Agree to Pay a Combined $36.95 Million to Resolve Whistleblower Claims Alleging Fraudulent Medicare Billing

Price target decreased by 12% to US$75.33

Strive, Inc. (NasdaqGM:ASST) entered into a definitive agreement to acquire Semler Scientific, Inc. (NasdaqCM:SMLR) for approximately $1.4 billion.

Semler Scientific, Inc. Enters into A Settlement Agreement with the Civil Fraud Section of the U.S. Department of Justice

Semler Scientific, Inc. Appoints William H.C. Chang as Class I Director

Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc

CEO, President & Director notifies of intention to sell stock

Is Semler Scientific (NASDAQ:SMLR) Using Too Much Debt?

Consensus EPS estimates increase from loss to US$0.24 profit

Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks

Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Revenue and earnings growth

Semler Scientific, Inc. to Report Q2, 2025 Results on Aug 04, 2025

Less than half of directors are independent

Semler Scientific, Inc.'s (NASDAQ:SMLR) 26% Share Price Surge Not Quite Adding Up

Semler Scientific, Inc., Annual General Meeting, Sep 05, 2025

Semler Scientific, Inc. Appoints Joe Burnett as Director of Bitcoin Strategy

Independent Chairman of the board exercised options to buy US$200k worth of stock.

Semler Scientific: Not The Ideal Bitcoin Treasury Company

Semler Scientific, Inc.'s (NASDAQ:SMLR) 32% Price Boost Is Out Of Tune With Revenues

New major risk - Financial position

First quarter 2025 earnings released: US$6.74 loss per share (vs US$0.88 profit in 1Q 2024)

Semler Scientific, Inc. to Report Q1, 2025 Results on May 13, 2025

Investor sentiment improves as stock rises 23%

Here's Why We Think Semler Scientific (NASDAQ:SMLR) Might Deserve Your Attention Today

Investor sentiment improves as stock rises 19%

Semler Scientific's (NASDAQ:SMLR) Profits May Not Reveal Underlying Issues

Semler Scientific, Inc. (NASDAQ:SMLR) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Investor sentiment deteriorates as stock falls 16%

Full year 2024 earnings released: EPS: US$5.66 (vs US$3.06 in FY 2023)

Now 27% undervalued

Consensus EPS estimates increase by 26%

New major risk - Revenue and earnings growth

Semler Scientific, Inc. to Report Q4, 2024 Results on Feb 18, 2025

Investor sentiment improves as stock rises 16%

New major risk - Shareholder dilution

Semler Scientific, Inc. (NASDAQ:SMLR) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Investor sentiment deteriorates as stock falls 24%

Now 28% undervalued

Investor sentiment improves as stock rises 23%

CEO, President & Director notifies of intention to sell stock

Semler Scientific: Booking Some Profits After Bitcoin Strategy

Now 25% undervalued

Investor sentiment improves as stock rises 43%

Independent Chairman of the board recently bought US$1.9m worth of stock

CEO, President & Director exercised options and sold US$1.7m worth of stock

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Investor sentiment improves as stock rises 22%

Semler Scientific, Inc. to Report Q3, 2024 Results on Nov 04, 2024

CEO, President & Director recently sold US$306k worth of stock

CEO, President & Director exercised options to buy US$2.0m worth of stock.

Semler Scientific, Inc., Annual General Meeting, Oct 04, 2024

Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: EPS: US$0.002 (vs US$0.88 in 2Q 2023)

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 20%

Semler Scientific, Inc. to Report Q2, 2024 Results on Aug 05, 2024

The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet

Semler Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $50 million.

Investor sentiment improves as stock rises 36%

Investor sentiment improves as stock rises 38%

Investor sentiment deteriorates as stock falls 17%

New minor risk - Shareholder dilution

Price target decreased by 38% to US$40.00

First quarter 2024 earnings: EPS and revenues miss analyst expectations

We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease

Semler Scientific, Inc. to Report Q1, 2024 Results on May 07, 2024

Many Still Looking Away From Semler Scientific, Inc. (NASDAQ:SMLR)

New minor risk - Shareholder dilution